InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,967.23
(
-0.88%
)
US TECH 100
16,556.80
(
-2.24%
)
Dow Jones
37,986.40
(
0.56%
)
Brent Oil
86.63
(
0.00%
)
Bitcoin
64,092.90
(
0.42%
)
Post# of 160314
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jaybird249

Send PM Follow Ignore
Followers 82
Posts 2822
Boards Moderated 0
Alias Born 05/05/2006

jaybird249

Re: None

Wednesday, 05/25/2011 2:56:19 PM

Wednesday, May 25, 2011 2:56:19 PM

Post# of 160314
RXII $.98 ASCO Blockbuster results

RXII could be $3 in no time like ZLCS and ACAD. RXII has a blockbuster cancer vaccine with unprecedented results approved for an SPA.

The vaccine reduced breast cancer recurrance from 14% to 2%. ober a 2 year period.

That trumps DNDN.

Updated results at ASCO.

Only 30 MM float and $20 MM cash. Market valuing thus vaccine at basically 0.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up